medical device investing Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
medical device investing ATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million
medical device investing Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
medical device investing Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results
medical device investing Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse Cardiac Catheter System at Heart Rhythm 2026
medical device investing Pulse Biosciences' nPulse Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting
medical device investing Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation
medical device investing Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation
medical device investing Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
medical device investing Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
medical device investing Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
medical device investing Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse Technology
Gold Resource Corporation Announces Special Shareholder Meeting to Vote on Strategic Merger With Goldgroup Mining
Blue Jay Gold Details Fully Funded Exploration Program at Steller Gold Project in Yukon and Confirms Listing Date
